<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">Patients who underwent LTX are usually poly medicated using many drug classes. The most important are immunosuppressive drugs. As most anti-COVID-19 agents are investigational, drug-drug interactions are very critical in this situation in those fragile patients. Possible drug-drug interactions between SARS-CoV-2 antiviral drugs and commonly used immunosuppressants for liver transplant recipients are presented in 
 <xref rid="t0005" ref-type="table">table 1</xref>
 <xref rid="b0275" ref-type="bibr">[55]</xref>, 
 <xref rid="b0280" ref-type="bibr">[56]</xref>, 
 <xref rid="b0285" ref-type="bibr">[57]</xref>. Possible interactions with other drugs are summarized below:
</p>
